compassionate use rare diseases – Clinical Research Made Simple

Immunotherapy Innovations for Rare Autoimmune Disorders

August 16, 2025

Immunotherapy Innovations for Rare Autoimmune Disorders How Immunotherapy Is Transforming Treatments for Rare Autoimmune Diseases Introduction: The Rise of Immunotherapy in Rare Autoimmune Disorders Rare autoimmune disorders such as neuromyelitis optica spectrum disorder (NMOSD), myasthenia gravis, and certain forms of systemic lupus erythematosus (SLE) affect small patient populations but often have devastating consequences. Historically, treatment…

Case Studies & Breakthroughs, Rare and Orphan Disease Trials

Understanding Orphan Drug Designation Benefits

August 4, 2025

digi

Understanding Orphan Drug Designation Benefits Unlocking the Value of Orphan Drug Designation for Rare Disease Development What Is Orphan Drug Designation and Why Does It Matter? Orphan Drug Designation (ODD) is a regulatory incentive program established to encourage the development of treatments for rare diseases, which often lack commercial appeal due to small patient populations….

Rare and Orphan Disease Trials, Regulatory Incentives